Name: UMIN ID:
Unique ID issued by UMIN | C000000345 |
---|---|
Receipt number | R000000443 |
Scientific Title | Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer. |
Date of disclosure of the study information | 2006/03/06 |
Last modified on | 2019/03/18 09:06:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2006/03/02 15:24:37 | ||
2 | Update | 2006/03/02 15:26:24 | Date of disclosure of the study information |
|
3 | Update | 2006/03/03 13:06:04 | Key inclusion criteria |
|
4 | Update | 2006/03/03 13:07:37 | Date of disclosure of the study information |
|
5 | Update | 2006/03/09 10:52:40 | Last follow-up date |
|
6 | Update | 2007/03/05 14:59:41 | ||
7 | Update | 2007/09/03 09:25:59 | Organization Organization Division name Division name Address Address |
|
8 | Update | 2008/03/03 13:15:06 | Recruitment status |
|
9 | Update | 2008/11/26 15:09:03 | Address Address TEL Address Address TEL Address1 Tel1 |
|
10 | Update | 2010/03/23 11:07:27 | Last name of contact person Last name of contact person Address Address TEL Address Institutions |
|
11 | Update | 2010/03/23 11:10:06 | Last follow-up date Publication of results Results |
|
12 | Update | 2011/03/02 10:03:43 | Results |
|
13 | Update | 2011/04/21 13:01:36 | Results |
|
14 | Update | 2011/09/02 09:42:46 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
15 | Update | 2013/09/02 09:05:25 | TEL |
|
16 | Update | 2019/03/18 08:40:29 | Recruitment status Date of IRB |
|
17 | Update | 2019/03/18 09:06:46 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |